Hikma Pharmaceuticals is a multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Hikma Pharmaceutical’s operations span 29 manufacturing plants in 11 countries: United States, Portugal, Italy, Jordan, Saudi Arabia, Algeria, Germany, Egypt, Morocco, Tunisia, and Sudan.

Type:                     Public

Traded as:    LSE: HIK;    FTSE 100 Component

Industry:              Pharmaceutical

Founded:            1978; 42 years ago

Founder:             Samih Darwazah

Headquarters:   London, England, UK

Products:             Amoclan; Prograf; Suprax

Website:              www.hikma.com